MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1791)	10/22/2007 2:49:01 AM
From: Icebrg	of 1826

Moulder and/or the MOGN staff have been extremely successful in bringing in new products to the company. A couple of years ago the only thing MOGN had under development was Irofulven. I is still under development, but they don't have to talk about it any more. Moulder is btw also good at selling. He was part of the founding management team and Vice President, Business Development and Commercial Affairs, of Eligix, which was taken over by BTRN. He seems to be a very smart guy, which I think is one of the main attractions with MOGN. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next